HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model

Anticancer Res. 2009 Dec;29(12):4901-8.

Abstract

Background: Statins are thought to have tumorolytic properties, reducing angiogenesis by inhibiting pro-angiogenic factors and inducing apoptosis of mural pericytes within the tumor vascular tree.

Materials and methods: An orthotopic mouse glioblastoma (GL-26) model was used to investigate the effect of simvastatin on glioblastoma vasculature in vivo. GL-26 cells were implanted into the striatum of C5LKa mice treated with either control, low- or high-dose simvastatin. Brains were analyzed for necrotic volume, apoptosis, morphology and pericytic cells within the vascular tree.

Results: Low-dose simvastatin increased necrosis and apoptosis compared to both control and high-dose simvastatin groups. High-dose simvastatin increased vessel caliber by reducing pericytic cells along the tumor vessel wall compared to both control and low-dose simvastatin groups.

Conclusion: Simvastatin has a dual effect on tumorigenesis. At high doses, it may worsen instead of 'normalizing' tumor angio-architecture, albeit low doses affect tumor cell survival by promoting necrosis and apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl Coenzyme A / antagonists & inhibitors*
  • Acyl Coenzyme A / metabolism
  • Animals
  • Apoptosis*
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Glioblastoma / metabolism
  • Glioblastoma / pathology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Immunoenzyme Techniques
  • Mice
  • Mice, Inbred C57BL
  • Necrosis
  • Neoplasms, Experimental
  • Neovascularization, Physiologic / drug effects
  • Simvastatin / pharmacology*

Substances

  • Acyl Coenzyme A
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • 3-hydroxy-3-methylglutaryl-coenzyme A
  • Simvastatin